CoChat
Sign Up
Cited by 786Antifungal resistance and susceptibilityFungal Infections and StudiesActinomycetales infections and treatment

The DOI matches its Crossref record; 497 of the 497 references it cites were found in a registry or an index.

Infections Caused by Scedosporium spp

Open access
Cortez, Karoll J., Roilides, Emmanuel, Quiroz-Telles, Flavio, Meletiadis, Joseph, Antachopoulos, Charalampos, Knudsen, Tena, Buchanan, Wendy, Milanovich, Jeffrey, Sutton, Deanna A., Fothergill, Annette, Rinaldi, Michael G., Shea, Yvonne R., Zaoutis, Theoklis, Kottilil, Shyam, Walsh, Thomas J.·2008·Clinical Microbiology Reviews
DOI 10.1128/cmr.00039-07PMC PMC2223844
Open this paper in CoChat — free account

Abstract

SUMMARY: Scedosporium spp. are increasingly recognized as causes of resistant life-threatening infections in immunocompromised patients. Scedosporium spp. also cause a wide spectrum of conditions, including mycetoma, saprobic involvement and colonization of the airways, sinopulmonary infections, extrapulmonary localized infections, and disseminated infections. Invasive scedosporium infections are also associated with central nervous infection following near-drowning accidents. The most common sites of infection are the lungs, sinuses, bones, joints, eyes, and brain. Scedosporium apiospermum and Scedosporium prolificans are the two principal medically important species of this genus. Pseudallescheria boydii , the teleomorph of S. apiospermum , is recognized by the presence of cleistothecia. Recent advances in molecular taxonomy have advanced the understanding of the genus Scedosporium and have demonstrated a wider range of species than heretofore recognized. Studies of the pathogenesis of and immune response to Scedosporium spp. underscore the importance of innate host defenses in protection against these organisms. Microbiological diagnosis of Scedosporium spp. currently depends upon culture and morphological characterization. Molecular tools for clinical microbiological detection of Scedosporium spp. are currently investigational. Infections caused by S. apiospermum and P. boydii in patients and animals may respond to antifungal triazoles. By comparison, infections caused by S. prolificans seldom respond to medical therapy alone. Surgery and reversal of immunosuppression may be the only effective therapeutic options for infections caused by S. prolificans .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/cmr.00039-07

Cites

497 of 497 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Items 401–497 of 497

Flagged first, then by citations

Research works printed but not linked: 15

  1. Ballingalli, G. R. 1855. An account of a tumor affecting the foot. Trans. Med. Phys. Soc. Bombay2:273-276.
  2. Brumpt, E. 1906. Les mycetomes. Arch. Parasitol.10:489-564.
  3. Carter, H. 1860. On a new striking form of fungus disease principally affecting the foot and prevailing endemically in many parts of India. Trans. Med. Phys. Soc. Bombay60:140-142.
  4. Carter, H. V. 1861. On mycetoma or the fungus disease of India including notes of recent cases and new observations of the structure, etc. of the entophytic growth. Trans. Med. Physiol. Soc. Bombay7:206-221.
  5. Dignani, M. C., N. Kiwan, and E. J. Anaissie. 2003. Hyalohyphomycoses, p. 309-324. In E. J. Anaissie, M. R. McGinnis, and M. A. Pfaller (ed.), Clinical mycology. Churchill Livingstone, Philadelphia, PA.
  6. Eyre, E. W. 1859. An account of a peculiar disease “tubercular” of the foot. Ind. Ann. Med. Sci.6:513-520.
  7. Godfrey, J. 1846. Diseases of the foot not hitherto described. Lanceti:593-594.
  8. Gueho, E., and G. S. de Hoog. 1991. Taxonomy of the medical species of Pseudallescheria and Scedosporium. J. Mycol. Méd.1:3-9.
  9. 10.1128/CMR.13.4.662 · DOI
  10. Malloch, D., and I. A. Salkin. 1984. A new species of Scedosporium associated with osteomyelitis in humans. Mycotaxon21:247-255.
  11. McGinnis, M. R., A. A. Padhye, and L. Ajello. 1982. Pseudallescheria Negroni et Fischer, 1943 and its later synonym Petriellidium Malloch, 1970. Mycotaxon14:94-102.
  12. Pinoy, E. 1913. Actinomycoses and mycetomas. Borntragen (Leipzig)11:929-938.
  13. Saccardo, P. A. 1911. Sylloge fungorum ommium hucusque cognitorum. Borntragen (Leipzig)4:282.
  14. Tarozzi, G. 1909. Ricerche anatomo-patologiehe, baceriologiehet e sperimentali sopra un caso di actinomicosi del piede. Arch. Perle Sc. Med.33:553-632.
  15. Werner, P. G. 2006. Myco-heterotrophs: hacking the mycorrhizal network. Mycena News57:8.

Cited by

Sorted by citations

See all 786

Related

See all

Metadata

Authors
Cortez, K. J., Roilides, E., Quiroz-Telles, F., Meletiadis, J., Antachopoulos, C., Knudsen, T., Buchanan, W., Milanovich, J., Sutton, D. A., Fothergill, A., Rinaldi, M. G., Shea, Y. R., Zaoutis, T., Kottilil, S., & Walsh, T. J.
Affiliations
  • Children's Hospital of Philadelphia (US)
  • Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland
  • National Institutes of Health (US)
Corresponding author
Walsh, Thomas J.
ORCID
Venue
Clinical Microbiology Reviews
Publisher
American Society for Microbiology
Published
2008-01
Volume
21
Issue
1
Pages
157-197
ISSN
  • 0893-8512 (ISSN-L)
  • 1098-6618
DOI
10.1128/cmr.00039-07
PMC
PMC2223844
OpenAlex
W2158059832
Cited by
786
References
497
Citations by year
2026: 31 · 2025: 47 · 2024: 52 · 2023: 59 · 2022: 29 · 2021: 42 · 2020: 48 · 2019: 36 · 2018: 35 · 2017: 68 · 2016: 45 · 2015: 46 · 2014: 41 · 2013: 50 · 2012: 31
FWCI
4.83
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Clinical Microbiology Reviews (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
  • Health Sciences › Medicine › Microbiology (medical) › Actinomycetales infections and treatment
Keywords
Scedosporium, Scedosporium apiospermum, Scedosporium prolificans, Pseudallescheria boydii, invasive fungal infections, immunocompromised patients, mycetoma, sinopulmonary infections, disseminated fungal infection, central nervous system infection, near-drowning, molecular taxonomy, pathogenesis, innate host defense, surgical debridement, molecular detection
MeSH terms
Administration, Inhalation, Animals, Antifungal Agents, Arthritis, Bone Diseases, Infectious, Humans, Immunosuppressive Agents, Mycetoma, Microbial Sensitivity Tests, Phylogeny, Respiratory Tract Infections, Eye Infections, Fungal, Immunocompromised Host, Central Nervous System Fungal Infections, Scedosporium, Biodiversity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review